Titrzepatide reduces risk of death or worsening heart failure for patients with obesity-related heart failure

Weight-loss and diabetes drug tirzepatide can reduce the risk of death or worsening heart failure for patients with heart failure, preserved heart pump function and obesity, new research from UVA Health reveals.

Inovalon Launches Converged Analytics Benchmarking for Health Plans

Inovalon, a provider of cloud-based software solutions for healthcare launches Converged Analytics Benchmarking, a revolutionary solution that empowers health plans to make data-driven decisions and

November 21, 2023

Paige Unveils AI Co-Pilot for Pathology & Oncology, Paige Alba

What You Should Know: – Paige, a provider of next-generation artificial intelligence has introduced Paige Alba, a groundbreaking clinical-grade multimodal co-pilot designed to transform personalized

September 6, 2024

Bristol Myers’ CAR-T therapy Breyanzi adds follicular lymphoma to list of approvals

Just two months after earning another approval for its blockbuster blood cancer drug Breyanzi, Bristol Myers Squibb can add an accelerated approval to the list,

May 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.